Dr. Rayne Rouce, MD

NPI: 1770774960
Total Payments
$38,308
2024 Payments
$1,488
Companies
4
Transactions
29

Payment Breakdown by Category

Consulting$33,765 (88.1%)
Travel$1,605 (4.2%)
Research$1,547 (4.0%)
Food & Beverage$1,337 (3.5%)
Gifts$55.00 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $33,765 7 88.1%
Travel and Lodging $1,605 5 4.2%
Unspecified $1,547 3 4.0%
Food and Beverage $1,337 13 3.5%
Gift $55.00 1 0.1%

Payments by Type

General
$36,761
26 transactions
Research
$1,547
3 transactions

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $19,511 18 $0 (2024)
PFIZER INC. $16,750 1 $0 (2022)
National Marrow Donor Program $1,964 9 $0 (2024)
Celgene Corporation $82.67 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,488 5 Novartis Pharmaceuticals Corporation ($939.64)
2023 $1,893 7 National Marrow Donor Program ($1,416)
2022 $16,926 2 PFIZER INC. ($16,750)
2021 $3,965 2 Novartis Pharmaceuticals Corporation ($3,965)
2019 $3,271 4 Novartis Pharmaceuticals Corporation ($3,271)
2018 $4,270 5 Novartis Pharmaceuticals Corporation ($4,188)
2017 $6,494 4 Novartis Pharmaceuticals Corporation ($6,494)

All Payment Transactions

29 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/15/2024 National Marrow Donor Program Gift In-kind items and services $55.00 General
06/07/2024 National Marrow Donor Program Travel and Lodging In-kind items and services $204.00 General
06/07/2024 National Marrow Donor Program Food and Beverage Cash or cash equivalent $75.00 General
04/28/2024 National Marrow Donor Program Food and Beverage In-kind items and services $214.51 General
02/06/2024 Novartis Pharmaceuticals Corporation KYMRIAH (Drug) Cash or cash equivalent $939.64 Research
Study: CCTL019B2401 • Category: Oncology
12/09/2023 Novartis Pharmaceuticals Corporation KYMRIAH (Drug) Food and Beverage In-kind items and services $45.98 General
Category: Oncology
09/29/2023 National Marrow Donor Program Food and Beverage In-kind items and services $75.00 General
08/04/2023 National Marrow Donor Program Travel and Lodging In-kind items and services $678.90 General
08/04/2023 National Marrow Donor Program Food and Beverage In-kind items and services $225.08 General
08/04/2023 National Marrow Donor Program Travel and Lodging In-kind items and services $60.11 General
06/16/2023 National Marrow Donor Program Travel and Lodging In-kind items and services $376.72 General
02/17/2023 Novartis Pharmaceuticals Corporation KYMRIAH (Drug) Cash or cash equivalent $431.05 Research
Study: CTL019B2401 • Category: Oncology
09/30/2022 NOVARTIS PHARMACEUTICALS CORPORATION KYMRIAH (Biological) In-kind items and services $176.00 Research
Study: PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH HEOR RESEARCH • Category: ONCOLOGY
01/17/2022 PFIZER INC. Consulting Fee Cash or cash equivalent $16,750.00 General
11/16/2021 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $1,525.00 General
Category: ONCOLOGY
03/24/2021 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Consulting Fee Cash or cash equivalent $2,440.00 General
Category: ONCOLOGY
12/05/2019 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $3,050.00 General
12/05/2019 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $109.48 General
11/12/2019 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Food and Beverage In-kind items and services $85.50 General
Category: ONCOLOGY
07/18/2019 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Food and Beverage In-kind items and services $26.33 General
Category: ONCOLOGY
11/29/2018 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $3,750.00 General
11/29/2018 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $285.00 General
11/29/2018 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $134.47 General
05/18/2018 Celgene Corporation Food and Beverage In-kind items and services $82.67 General
02/23/2018 Novartis Pharmaceuticals Corporation KYMRIAH (Biological) Food and Beverage In-kind items and services $18.34 General
Category: ONCOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
CCTL019B2401 Novartis Pharmaceuticals Corporation $939.64 1
CTL019B2401 Novartis Pharmaceuticals Corporation $431.05 1
PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH HEOR RESEARCH NOVARTIS PHARMACEUTICALS CORPORATION $176.00 1

About Dr. Rayne Rouce, MD

Dr. Rayne Rouce, MD is a Pediatrics healthcare provider based in Galveston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770774960.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rayne Rouce, MD has received a total of $38,308 in payments from pharmaceutical and medical device companies, with $1,488 received in 2024. These payments were reported across 29 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($33,765).

Practice Information

  • Specialty Pediatrics
  • Location Galveston, TX
  • Active Since 08/05/2007
  • Last Updated 08/05/2007
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1770774960

Products in Payments

  • KYMRIAH (Biological) $8,779
  • KYMRIAH (Drug) $1,417

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Galveston